Buy IP Tokens of IPNFT #129 (CLAW) in Japan

IP Tokens of IPNFT 129, represented by the symbol CLAW, is a decentralized science (DeSci) project that bridges intellectual property with blockchain technology. This initiative is part of the BIO Protocol ecosystem and was developed in collaboration with Cerebrum DAO. The project focuses on advancing research for brain health and neurodegenerative conditions, specifically targeting cognitive decline and memory loss. The intellectual property associated with this token belongs to Percepta, a patent-protected dietary supplement designed to support brain health. The core active ingredients of Percepta include a specific extract of Uncaria tomentosa, commonly known as Cat’s claw, and a proprietary oolong tea extract called MemorTea. The project aims to fund and conduct clinical studies that could eventually lead to FDA botanical drug status, providing a scientifically validated solution for brain health. The naming of the token and its designation as IPNFT 129 is a deliberate dual reference. Literally, it points to the Cat’s claw botanical ingredient. Metaphorically, it pays tribute to a Cold War mission known as Project Azorian, where the CIA used a massive mechanical claw to retrieve a sunken Soviet submarine designated K-129. Just as the historical mission sought to recover valuable information from the depths, this project seeks to extract and validate life-changing scientific data for the public good. By tokenizing this intellectual property, the project allows for the fractionalization of research assets. Holders of CLAW tokens can participate in the governance of the IP, influencing how the research is developed, licensed, and commercialized. This model aims to create a more transparent and community-driven approach to biomedical funding, moving away from traditional pharmaceutical models to allow patient collectives and researchers to collaborate directly. The project is hosted on the Base and Ethereum networks. It represents a significant milestone in the DeSci movement by being one of the first instances where a robust patent portfolio and clinical study framework have been tokenized for public participation. The ultimate objective is to improve global access to effective brain health treatments through a decentralized, transparent research and development process. Learn more